Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Prepaid Assets (2016 - 2025)

VYNE Therapeutics (VYNE) has disclosed Prepaid Assets for 10 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets fell 65.7% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Dec 2025, down 65.7%, and an annual FY2025 reading of $1.0 million, down 65.7% over the prior year.
  • Prepaid Assets was $1.0 million for Q4 2025 at VYNE Therapeutics, down from $4.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.6 million in Q2 2024 and bottomed at $1.0 million in Q4 2025.
  • Average Prepaid Assets over 5 years is $3.5 million, with a median of $3.8 million recorded in 2022.
  • The sharpest move saw Prepaid Assets skyrocketed 178.11% in 2024, then crashed 65.7% in 2025.
  • Year by year, Prepaid Assets stood at $4.6 million in 2021, then crashed by 49.62% to $2.3 million in 2022, then increased by 15.48% to $2.7 million in 2023, then grew by 9.98% to $2.9 million in 2024, then plummeted by 65.7% to $1.0 million in 2025.
  • Business Quant data shows Prepaid Assets for VYNE at $1.0 million in Q4 2025, $4.7 million in Q2 2025, and $4.6 million in Q1 2025.